Health Care & Life Sciences » Pharmaceuticals | Rui Kang Pharmaceutical Group Investments Ltd.

Rui Kang Pharmaceutical Group Investments Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2012
2014
2015
2016
2017
2018
Net Income before Extraordinaries
22,692.00
74,398.00
60,040.00
95,139.00
75,398.00
69,244
Depreciation, Depletion & Amortization
2,299.00
950.00
4,064.00
7,157.00
7,271.00
8,246
Other Funds
160.00
-
-
-
-
9,842
Funds from Operations
10,386.00
24,079.00
37,056.00
24,240.00
31,608.00
51,156
Changes in Working Capital
8,812.00
15,653.00
5,573.00
35,034.00
45,606.00
33,056
Net Operating Cash Flow
1,574.00
39,732.00
42,629.00
10,794.00
77,214.00
18,100
Capital Expenditures
791.00
2,763.00
9,840.00
8,207.00
5,070.00
Sale of Fixed Assets & Businesses
291.00
-
100.00
85.00
10,278.00
Purchase/Sale of Investments
-
-
525.00
48,167.00
35,960.00
Net Investing Cash Flow
500.00
33,507.00
96,433.00
61,007.00
41,168.00
Issuance/Reduction of Debt, Net
64.00
31,082.00
1,917.00
20,332.00
6,613.00
Net Financing Cash Flow
28,792.00
89,558.00
217,942.00
41,568.00
54,163.00
Net Change in Cash
26,868.00
16,316.00
78,116.00
9,517.00
20,279.00
Free Cash Flow
2,365.00
42,495.00
52,469.00
2,587.00
82,284.00
Net Assets from Acquisitions
-
30,744.00
87,218.00
15,206.00
-
Other Sources
-
-
-
10,488.00
-
Change in Capital Stock
29,016.00
120,640.00
216,025.00
21,236.00
47,550.00
Exchange Rate Effect
150.00
3.00
764.00
872.00
2,162.00

About Rui Kang Pharmaceutical Group Investments

View Profile
Address
Suites 1904-05A, 19/F, Sino Plaza
Hong Kong
Hong Kong
Employees -
Website http://www.cbshhk.com
Updated 07/08/2019
China Biotech Services Holdings Ltd. is an investment company, which engages in the provision of medical laboratory testing, and health check services. It operates through the following segments: Pharmaceutical Products, Medical and Health Related Services, Securities, and Others. The Pharmaceutical Products segment manufactures, researches, develops, sells, and distributes health related and pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.